Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMCOpen access

Silk fibroin-collagen hydrogel loaded with IGF1-CESCs attenuates intervertebral disk degeneration by accelerating annulus fibrosus healing in rats

Tian Z., Shen Z., Chen H., Zhao P.

Laboratory Study on Disc Degeneration, Chronic Wound, published in Front Pharmacol (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Front Pharmacol (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40213695
PMCID
PMC11983619
DOI
10.3389/fphar.2025.1552174
Citations
2

Abstract (original English)

Introduction: The self-healing capacity of a damaged annulus fibrosus (AF) leads to intervertebral disk (IVD) degeneration. AF wound treatment is challenging. The combination of biomaterials and stem cell-derived exosomes is a promising wound treatment strategy with significant clinical value. Methods: We isolate primary nucleus pulposus cells (NPCs) and primary annulus fibrosus cells (AFCs) from rats as the target cells of rat insulin-like growth factor 1(IGF1), and verify the proliferation and migration; constructed cartilage endplate stem cells (CESCs) engineered cells that release exosomes containing high concentrations of IGF1by lentiviral infection, and used the IGF1-CESCs combined with combined silk fibroin (SF) and a collagen-mixed hydrogel for the treatment of AF wounds in rat. Results: We found that both IGF1 and IGF1-rich exosomes (IGF1 Exo) promoted the proliferation and migration of AFCs. SF and collagen mixed hydrogels have excellent compressive mechanical properties and are suitable for use in IVD therapy. After the IGF1-CESCs@SF-collagen hydrogel was filled in the damaged area of the AF in rat, the wound healing was accelerated, nucleus pulposus overflow was inhibited, the IVD height was maintained, and degeneration was reduced. Discussion: The IGF1-CESCs@SF-collagen hydrogel can efficiently treat AF wounds and inhibit degeneration of IVD, and has potential for

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research